Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are administered 2 months apart for children aged 12–23 months, with a booster dose 12–24 months later. Our objective was to provide data on persistence of human serum bactericidal antibody (hSBA) titres i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:CMAJ
Huvudupphovsmän: Sadarangani, Manish, Sell, Tim, Iro, Mildred A., Snape, Matthew D., Voysey, Merryn, Finn, Adam, Heath, Paul T., Bona, Gianni, Esposito, Susanna, Diez-Domingo, Javier, Prymula, Roman, Odueyungbo, Adefowope, Toneatto, Daniela, Pollard, Andrew J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Joule Inc. 2017
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5647166/
https://ncbi.nlm.nih.gov/pubmed/29038320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.161288
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk